In recent years, MGL has emerged as a crucial regulator of 2-AG, involved in many pathophysiological processes, such as stress, metabolic syndrome, pain, and inflammation (reviewed in Grabner et al5). The gene discussed is MGLL; the disease is metabolic syndrome.